NCT00185913
Completed
Not Applicable
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
ConditionsLung Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Stanford University
- Enrollment
- 50
- Locations
- 1
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Exclusion Criteria
- •Patients without non-small cell lung cancer
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersHead and Neck CancerLung CancerLip CancerLip NeoplasmsHead and Neck CancersNCT00568490Stanford University200
Terminated
Not Applicable
The Role of Hypoxia as a Selective Pressure for TP53 MutationsEndometrial CancerNCT03466034Institute of Cancer Research, United Kingdom5
Withdrawn
Not Applicable
Characterize Tumor Hypoxia by Magnetic Resonance ImagingProstate CancerProstate TumorNCT03987568Wake Forest University Health Sciences
Completed
Not Applicable
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) PatientsNon-Small-Cell-Lung Cancer (NSCLC)NCT02016872Memorial Sloan Kettering Cancer Center25
Unknown
Phase 2
Hypoxia Analysis in Head and/or Neck CancerHead and Neck CancerNCT02414048Marius Gustav Bredell10